Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 8.83B | 7.62B | 6.66B | 4.80B | 3.86B |
Gross Profit | 1.87B | 4.10B | 3.81B | 2.80B | 2.10B |
EBITDA | 1.63B | 1.44B | 1.18B | 900.18M | 683.81M |
Net Income | 1.09B | 961.74M | 819.77M | 632.62M | 454.44M |
Balance Sheet | |||||
Total Assets | 9.93B | 7.86B | 5.68B | 4.62B | 3.65B |
Cash, Cash Equivalents and Short-Term Investments | 1.97B | 2.07B | 1.53B | 1.05B | 1.00B |
Total Debt | 754.52M | 263.46M | 135.27M | 206.79M | 350.55M |
Total Liabilities | 3.74B | 2.81B | 1.64B | 1.43B | 1.06B |
Stockholders Equity | 6.19B | 5.05B | 4.05B | 3.18B | 2.59B |
Cash Flow | |||||
Free Cash Flow | 1.01B | 1.15B | 763.31M | 505.42M | 627.11M |
Operating Cash Flow | 1.05B | 1.17B | 841.04M | 701.17M | 697.78M |
Investing Cash Flow | -1.06B | -637.68M | -593.61M | -417.13M | -114.52M |
Financing Cash Flow | 276.46M | 10.54M | -107.37M | -235.63M | -112.51M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | ₹27.35B | 22.72 | 0.39% | 19.50% | 18.47% | ||
68 Neutral | ₹26.31B | 15.71 | 1.25% | 4.85% | 1.23% | ||
60 Neutral | ₹19.05B | 38.96 | ― | 868.33% | ― | ||
57 Neutral | €1.69B | 12.24 | 1.59% | 3.67% | 2.96% | -106.86% | |
57 Neutral | ₹14.66B | 65.77 | 0.52% | 4.89% | -62.30% | ||
54 Neutral | ₹15.20B | 35.40 | 1.07% | 11.08% | -3.05% | ||
53 Neutral | ₹36.50B | 1,312.18 | 0.24% | 6.27% | -443.60% |
Saksoft Limited announced the approval of its unaudited financial results for the quarter ending June 30, 2025, with no adverse remarks from auditors. Additionally, the company approved a Scheme of Amalgamation with Augmento Labs Private Limited, subject to necessary approvals, which may enhance its market position and operational capabilities.